MX2013008715A - Uso de (s) -esmolol para controlar la irritacion venosa asociada con el tratamiento de un padecimiento cardiaco. - Google Patents
Uso de (s) -esmolol para controlar la irritacion venosa asociada con el tratamiento de un padecimiento cardiaco.Info
- Publication number
- MX2013008715A MX2013008715A MX2013008715A MX2013008715A MX2013008715A MX 2013008715 A MX2013008715 A MX 2013008715A MX 2013008715 A MX2013008715 A MX 2013008715A MX 2013008715 A MX2013008715 A MX 2013008715A MX 2013008715 A MX2013008715 A MX 2013008715A
- Authority
- MX
- Mexico
- Prior art keywords
- esmolol
- treatment
- isopropylamino
- propoxy
- cardiac disorder
- Prior art date
Links
- 208000020446 Cardiac disease Diseases 0.000 title abstract 2
- 208000019622 heart disease Diseases 0.000 title abstract 2
- AQNDDEOPVVGCPG-AWEZNQCLSA-N (S)-esmolol Chemical compound COC(=O)CCC1=CC=C(OC[C@@H](O)CNC(C)C)C=C1 AQNDDEOPVVGCPG-AWEZNQCLSA-N 0.000 title 1
- 230000007794 irritation Effects 0.000 title 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 abstract 3
- DYUMLJSJISTVPV-UHFFFAOYSA-N phenyl propanoate Chemical compound CCC(=O)OC1=CC=CC=C1 DYUMLJSJISTVPV-UHFFFAOYSA-N 0.000 abstract 2
- GXLJZLBKWSJXFP-UHFFFAOYSA-N phenyl propanoate;hydrochloride Chemical compound Cl.CCC(=O)OC1=CC=CC=C1 GXLJZLBKWSJXFP-UHFFFAOYSA-N 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161436995P | 2011-01-27 | 2011-01-27 | |
| PCT/US2012/022679 WO2012103305A1 (en) | 2011-01-27 | 2012-01-26 | Use of (s) - esmolol for controlling venous irritation associated with the treatment of a cardiac disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2013008715A true MX2013008715A (es) | 2013-08-29 |
Family
ID=45567140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013008715A MX2013008715A (es) | 2011-01-27 | 2012-01-26 | Uso de (s) -esmolol para controlar la irritacion venosa asociada con el tratamiento de un padecimiento cardiaco. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8829047B2 (enExample) |
| EP (1) | EP2667866B1 (enExample) |
| JP (1) | JP2014511365A (enExample) |
| KR (1) | KR20140019334A (enExample) |
| CN (1) | CN103347513A (enExample) |
| AU (1) | AU2012211309B2 (enExample) |
| BR (1) | BR112013018598A2 (enExample) |
| CA (1) | CA2825716A1 (enExample) |
| MX (1) | MX2013008715A (enExample) |
| WO (1) | WO2012103305A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012211318C1 (en) | 2011-01-27 | 2016-08-04 | Baxter Healthcare S.A. | Methods of treating tachycardia and/or controlling heart rate while minimizing and/or controlling hypotension |
| US10307167B2 (en) | 2012-12-14 | 2019-06-04 | Corquest Medical, Inc. | Assembly and method for left atrial appendage occlusion |
| US10314594B2 (en) | 2012-12-14 | 2019-06-11 | Corquest Medical, Inc. | Assembly and method for left atrial appendage occlusion |
| US10813630B2 (en) | 2011-08-09 | 2020-10-27 | Corquest Medical, Inc. | Closure system for atrial wall |
| US20140142689A1 (en) | 2012-11-21 | 2014-05-22 | Didier De Canniere | Device and method of treating heart valve malfunction |
| US9566443B2 (en) | 2013-11-26 | 2017-02-14 | Corquest Medical, Inc. | System for treating heart valve malfunction including mitral regurgitation |
| US10842626B2 (en) | 2014-12-09 | 2020-11-24 | Didier De Canniere | Intracardiac device to correct mitral regurgitation |
| EP4490042A4 (en) | 2022-03-08 | 2026-03-04 | Equashield Medical Ltd | FLUID TRANSFER STATION IN A ROBOTIC PHARMACEUTICAL PREPARATION SYSTEM |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU575153B2 (en) | 1984-04-09 | 1988-07-21 | Du Pont Merck Pharmaceutical Company, The | Pharmaceutical compositions and method for treatment for prophylaxis of cardiac disorders |
| JPS63502585A (ja) | 1985-12-04 | 1988-09-29 | ザ デュポン メルク ファーマシュウティカル カンパニー | アリルオキシプロパノ−ルアミン類及びアリルエタノ−ルアミン類の合成法 |
| AU607437B2 (en) | 1986-09-02 | 1991-03-07 | Du Pont Pharmaceuticals Company | Resolution of dl-methyl 3-(4-(2-hydroxy-3-isopropylamino) propoxy)phenylpropionate((dl-esmolol)) |
| US4857552A (en) | 1988-06-08 | 1989-08-15 | E. I. Du Pont De Nemours And Co. | Stable pharmaceutical composition |
| US5849843A (en) | 1993-11-16 | 1998-12-15 | Baxter International Inc. | Polymeric compositions for medical packaging and devices |
| US5998019A (en) | 1993-11-16 | 1999-12-07 | Baxter International Inc. | Multi-layered polymer structure for medical products |
| US5977409A (en) * | 1997-04-15 | 1999-11-02 | University Of Toledo | Method of using α-substituted benzylamine chiral auxiliary synthetic reagents |
| TWI277414B (en) * | 2001-01-12 | 2007-04-01 | Baxter Int | Esmolol formulation |
| US6310094B1 (en) * | 2001-01-12 | 2001-10-30 | Baxter International Inc. | Ready-to-use esmolol solution |
| ATE533509T1 (de) | 2003-08-08 | 2011-12-15 | Ono Pharmaceutical Co | Herzverlangsamender arzneistoff mit beta-blockern mit kurzzeitwirkung als wirkstoff |
| US20080293814A1 (en) * | 2007-05-22 | 2008-11-27 | Deepak Tiwari | Concentrate esmolol |
| CN101323580A (zh) | 2008-07-25 | 2008-12-17 | 河北科技大学 | 手性芳氧丙醇胺类化合物及其盐的合成方法 |
| CN101881755B (zh) | 2009-05-04 | 2013-05-29 | 南京海辰药业有限公司 | 通过高效液相色谱法检测盐酸艾司洛尔光学异构体的方法 |
| CN101891636A (zh) | 2009-05-21 | 2010-11-24 | 南京海辰药业有限公司 | 制备盐酸艾司洛尔光学异构体的新方法 |
| CN102106846A (zh) | 2009-12-23 | 2011-06-29 | 南京海辰药业有限公司 | 左旋盐酸艾司洛尔药物组合物及其制备方法 |
| AU2012211318C1 (en) | 2011-01-27 | 2016-08-04 | Baxter Healthcare S.A. | Methods of treating tachycardia and/or controlling heart rate while minimizing and/or controlling hypotension |
-
2012
- 2012-01-26 CN CN2012800067439A patent/CN103347513A/zh active Pending
- 2012-01-26 BR BR112013018598A patent/BR112013018598A2/pt not_active IP Right Cessation
- 2012-01-26 WO PCT/US2012/022679 patent/WO2012103305A1/en not_active Ceased
- 2012-01-26 MX MX2013008715A patent/MX2013008715A/es active IP Right Grant
- 2012-01-26 JP JP2013551325A patent/JP2014511365A/ja not_active Withdrawn
- 2012-01-26 AU AU2012211309A patent/AU2012211309B2/en not_active Ceased
- 2012-01-26 US US13/358,949 patent/US8829047B2/en active Active
- 2012-01-26 KR KR1020137022490A patent/KR20140019334A/ko not_active Withdrawn
- 2012-01-26 EP EP20120702940 patent/EP2667866B1/en not_active Not-in-force
- 2012-01-26 CA CA2825716A patent/CA2825716A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BR112013018598A2 (pt) | 2016-10-18 |
| EP2667866A1 (en) | 2013-12-04 |
| KR20140019334A (ko) | 2014-02-14 |
| JP2014511365A (ja) | 2014-05-15 |
| US20120277309A1 (en) | 2012-11-01 |
| AU2012211309B2 (en) | 2014-10-09 |
| WO2012103305A1 (en) | 2012-08-02 |
| CA2825716A1 (en) | 2012-08-02 |
| CN103347513A (zh) | 2013-10-09 |
| US8829047B2 (en) | 2014-09-09 |
| AU2012211309A1 (en) | 2013-05-02 |
| EP2667866B1 (en) | 2015-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| MX2025005489A (es) | Uso de lumateperona para el tratamiento del trastorno bipolar ii | |
| MX2011007854A (es) | Metodos para tratar infartos agudos al miocardio y trastornos relacionados. | |
| MX2020011653A (es) | Métodos de tratamiento para el abuso de sustancias. | |
| PH12014501491A1 (en) | Subcutaneous therapeutic use of dpp-4 inhibitor | |
| EA201491773A1 (ru) | Лечение рассеянного склероза комбинацией лаквинимода и диметилфумарата | |
| BR112012033738A2 (pt) | método para o tratamento de transtorno bipolar | |
| PH12012501739A1 (en) | Treatment of lupus nephritis using laquinimod | |
| MX2010013766A (es) | Rasagilina para modificacion de enfermedad de parkinson. | |
| HK1204988A1 (en) | Methods and compositions for preventing or treating ophthalmic conditions | |
| EA201490378A1 (ru) | ЛЕЧЕНИЕ РАССЕЯННОГО СКЛЕРОЗА С ИСПОЛЬЗОВАНИЕМ КОМБИНАЦИИ ЛАХИНИМОДА И ИНТЕРФЕРОНА-β | |
| BR112012022064A2 (pt) | tratamento de artrite lúpica usando laquinimod | |
| MY170198A (en) | Agent for treatment of dry eye characterized by combining p2y2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof | |
| MX2015006120A (es) | Compuestos novedosos oralmente biodisponibles que modulan el control de la respiracion, y metodos de uso de los mismos. | |
| EA201490004A1 (ru) | Применение bifidobacterium lactis bl-04 для лечения заболеваний дыхательных путей | |
| BR112013018598A2 (pt) | composição farmacêutica, método para tratar uma doença cardíaca, uso de (s)-metil-3-[4-(2-hidroxi-3-[4-(2-hidroxi-3-isopropilamino) propoxi] fenilpropionato, e, método para controlar frequência cardíaca | |
| MX350195B (es) | Analogos de cistamina para el tratamiento de la enfermedad de parkinson. | |
| BR112014010729A2 (pt) | métodos para tratamento de ataques de gota | |
| MX389282B (es) | Composiciones y métodos para tratar sinucleinopatías. | |
| TW201129361A (en) | Methods for treating pain | |
| WO2013169291A3 (en) | Method for inducing udp-glucuronosyltransferase activity using pterostilbene | |
| EA201690903A1 (ru) | Лечение глаукомы с использованием лаквинимода | |
| WO2013181217A3 (en) | Novel compounds and compositions for treatment of breathing control disorders or diseases | |
| UA109359C2 (xx) | Лікування захворювань і станів шкіри 7-(1h-імідазол-4-ілметил)-5,6,7,8-тетрагідрохіноліном | |
| MX348723B (es) | Combinaciones de solifenacina y estimulantes salivales para el tratamiento de la vejiga hiperactiva. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |